Rachel Sayko Adams1, Mary Jo Larson, Esther L Meerwijk, Thomas V Williams, Alex H S Harris. 1. Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Drs Adams and Larson); Center for Innovation to Implementation, VA Palo Alto Health Care System, Palo Alto, California (Drs Meerwijk and Harris); and NORC at the University of Chicago, Bethesda, Maryland (Dr Williams).
Abstract
OBJECTIVES: To determine the proportion of Army soldiers who utilized care in the Veterans Health Administration (VHA) Polytrauma System of Care (PSC) within the postdeployment year and to describe prevalence of polytrauma diagnoses, and receipt of opioids, nonpharmacologic treatments (NPTs), and mental health treatments in the VHA during the year following first PSC utilization. SETTING: VHA's 4-tiered integrated PSC network of specialized rehabilitation services for military members and veterans with polytrauma. PARTICIPANTS: Soldiers and veterans who used the PSC during the postdeployment year after an Afghanistan or Iraq deployment ending in fiscal years 2008-2011. DESIGN: Population-based cohort study. MAIN MEASURES: Prevalence of polytrauma diagnoses (ie, traumatic brain injury [TBI], posttraumatic stress disorder [PTSD], and chronic pain [CP]), VHA utilization rates of opioid prescriptions, NPT, and specialty mental health treatment within 1 year of PSC utilization. RESULTS: In total, 2.6% of the sample (n = 16 590) used the PSC during the postdeployment year. Among PSC users, CP (76.5%), PTSD (53.1%), and TBI (48.6%) were common and more frequently found together than in isolation; 26.6% filled an opioid prescription, 35.5% received at least 1 NPT, and 83.8% received specialty mental health treatment in the VHA within 1 year of PSC utilization. CONCLUSION: CP was the most common polytrauma condition among PSC users, highlighting the importance of incorporating interdisciplinary pain management approaches within the PSC, with an effort to reduce reliance on long-term opioid therapy and improve rehabilitation.
OBJECTIVES: To determine the proportion of Army soldiers who utilized care in the Veterans Health Administration (VHA) Polytrauma System of Care (PSC) within the postdeployment year and to describe prevalence of polytrauma diagnoses, and receipt of opioids, nonpharmacologic treatments (NPTs), and mental health treatments in the VHA during the year following first PSC utilization. SETTING: VHA's 4-tiered integrated PSC network of specialized rehabilitation services for military members and veterans with polytrauma. PARTICIPANTS: Soldiers and veterans who used the PSC during the postdeployment year after an Afghanistan or Iraq deployment ending in fiscal years 2008-2011. DESIGN: Population-based cohort study. MAIN MEASURES: Prevalence of polytrauma diagnoses (ie, traumatic brain injury [TBI], posttraumatic stress disorder [PTSD], and chronic pain [CP]), VHA utilization rates of opioid prescriptions, NPT, and specialty mental health treatment within 1 year of PSC utilization. RESULTS: In total, 2.6% of the sample (n = 16 590) used the PSC during the postdeployment year. Among PSC users, CP (76.5%), PTSD (53.1%), and TBI (48.6%) were common and more frequently found together than in isolation; 26.6% filled an opioid prescription, 35.5% received at least 1 NPT, and 83.8% received specialty mental health treatment in the VHA within 1 year of PSC utilization. CONCLUSION: CP was the most common polytrauma condition among PSC users, highlighting the importance of incorporating interdisciplinary pain management approaches within the PSC, with an effort to reduce reliance on long-term opioid therapy and improve rehabilitation.
Authors: Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin Journal: Ann Intern Med Date: 2007-01-16 Impact factor: 25.391
Authors: Megan E Vanneman; Alex H S Harris; Cheng Chen; Rachel Sayko Adams; Thomas V Williams; Mary Jo Larson Journal: Psychiatr Serv Date: 2017-04-17 Impact factor: 3.084
Authors: Nina A Sayer; David X Cifu; Shane McNamee; Christine E Chiros; Barbara J Sigford; Steve Scott; Henry L Lew Journal: PM R Date: 2009-01 Impact factor: 2.298
Authors: Mary Jo Larson; Rachel Sayko Adams; Grant A Ritter; Andrea Linton; Thomas V Williams; Mayada Saadoun; Mark R Bauer Journal: J Altern Complement Med Date: 2018-03-28 Impact factor: 2.579
Authors: Mary Jo V Pugh; Erin P Finley; Laurel A Copeland; Chen-Pin Wang; Polly H Noel; Megan E Amuan; Helen M Parsons; Margaret Wells; Barbara Elizondo; Jacqueline A Pugh Journal: Med Care Date: 2014-02 Impact factor: 2.983
Authors: Raj G Kumar; Katherine A Ornstein; John D Corrigan; Rachel Sayko Adams; Kristen Dams-O'Connor Journal: J Neurotrauma Date: 2021-03-11 Impact factor: 4.869